L-Nutra announced it has secured a $36.5 million investment led by Mubadala Investment Company as part of its Series D round, bringing total Series D proceeds to $83.5 million. The company is pushing to expand internationally and scale its “nutrition as medicine” and longevity-focused programs.
The Los Angeles-based nutrition technology company said the financing will support a new joint venture in Abu Dhabi to produce and distribute its scientific medical nutrition therapies and longevity nutrition offerings across the Middle East and North Africa. L-Nutra and Mubadala said they have already begun delivering healthier nutrition and education programs across seven schools in Abu Dhabi.
L-Nutra positions its platform around clinically validated nutrition programs designed to support healthy aging and improve outcomes in chronic conditions, including programs marketed under the Prolon brand and other medical nutrition therapies. The company said its work is supported by partnerships with 18 university research centers and underpinned by 47 clinical trials, 137 granted patents, and a growing global footprint.
Mubadala framed the investment as part of its broader effort to build Abu Dhabi into a regional hub for longevity science, preventive health, and advanced nutrition technologies, alongside other initiatives within the UAE’s life sciences ecosystem.
L-Nutra said Mubadala’s investment adds to an existing investor base that includes Brentwood Associates, Moderna CEO Stéphane Bancel, and 618 Ventures.
KEY QUOTES:
“We are on the cusp of enhancing human healthspan, adding years to our life and life to our years. As the world’s first nutri-technology company, we have spent decades advancing nutrition R&D and developing effective interventions that can be integrated within our healthcare system… By reformulating food into clinically validated nutrition programs, we now can support patients and individuals seeking to embark on a healthy longevity journey.”
Joseph Antoun, MD, PhD, Chairman and CEO, L-Nutra
“This investment reinforces Abu Dhabi’s ambition to expand as a regional hub for longevity science, preventive health, and advanced nutrition technologies, and operates as a natural extension of the sector capabilities we are building across the UAE’s emerging life sciences ecosystem… We look forward to supporting L-Nutra’s international expansion, including across the MENA region through localized development of its core technologies in Abu Dhabi, while further advancing the UAE’s economic diversification and knowledge-based economy.”
Ismail Ali Abdulla, Executive Director of UAE Clusters, Mubadala’s UAE Investment Platform
